ZHOU Jing, WANG Fugen. Connexin, Pannexin1: A novel therapeutic target for acute liver injury[J]. Chinese Journal of Modern Applied Pharmacy, 2023, 40(3): 427-432. DOI: 10.13748/j.cnki.issn1007-7693.2023.03.024
    Citation: ZHOU Jing, WANG Fugen. Connexin, Pannexin1: A novel therapeutic target for acute liver injury[J]. Chinese Journal of Modern Applied Pharmacy, 2023, 40(3): 427-432. DOI: 10.13748/j.cnki.issn1007-7693.2023.03.024

    Connexin, Pannexin1: A novel therapeutic target for acute liver injury

    • Gap junction intercellular communication(GJIC) plays an important role in maintaining the homeostasis of the liver and liver function. The dysfunction of gap junction can cause abnormal cell differentiation, cell death, inflammation, fibrosis, liver cirrhosis and liver cancer. In recent years, more and more evidences have shown that the expression of Connexins and Pannexin1(Panx1) are changed and disorders of intercellular communication in acute liver injury. Based on Connexin, Panx1, gap junction, and channel inhibitors were summaried in this paper, which may provide new perspectives and potential therapeutic agents for the treatment of actue liver injury.
    • loading

    Catalog

      Turn off MathJax
      Article Contents

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return